LevitasBio Completes Series C Financing

other

▤ Summary

MENLO PARK, CA, LevitasBio, an end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing. LevitasBio, an end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies